Back to Results
First PageMeta Content
Shionogi / Menopause / Dyspareunia / Estrogen / Vaginal lubrication / Human reproduction / Endocrine system / Reproductive system


Shionogi receives Marketing Authorisation approval for Senshio® (ospemifene) in Europe for the treatment of moderate to severe symptomatic vulvar and vaginal atrophy (VVA) in post-menopausal women Osaka, Japan January 1
Add to Reading List

Document Date: 2015-01-27 15:09:34


Open Document

File Size: 50,94 KB

Share Result on Facebook
UPDATE